Insider Trading / SAST

Biogen Pharmachem Industries has closed its trading window for company insiders starting July 1, 2026. This move is a standard measure to prevent insider trading ahead of its upcoming financial results for the first quarter ended June 30, 2026. The window will reopen 48 hours after these results are publicly announced.

The company will inform shareholders about the board meeting date to approve these financial results in due course.